Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis

Despite considerable advances in the treatment of multiple sclerosis, current drugs are only partially effective. Most patients show reduced disease activity with therapy, but still experience relapses, increasing disability, and new brain lesions. Since there are no reliable clinical or biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Hecker, Michael, Paap, Brigitte Katrin, Goertsches, Robert Hermann, Kandulski, Ole, Fatum, Christian, Koczan, Dirk, Hartung, Hans-Peter, Thiesen, Hans-Juergen, Zettl, Uwe Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246503/
https://www.ncbi.nlm.nih.gov/pubmed/22216338
http://dx.doi.org/10.1371/journal.pone.0029648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246503/
https://www.ncbi.nlm.nih.gov/pubmed/22216338
http://dx.doi.org/10.1371/journal.pone.0029648

Ejemplares similares